5501 - 5525 of 6255 Results
Title
Year
- Biallelic NDUFA13 variants lead to a neurodevelopmental phenotype with gradual neurological impairment2024OPENTitle: Biallelic NDUFA13 variants lead to a neurodevelopmental phenotype with gradual neurological impairmentJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae453Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae453/61218229/fcae453.pdfCitation Count: 2
- Pathogenic LRRK2 regulates ciliation probability upstream of tau tubulin kinase 2 via Rab10 and RILPL1 proteins2021OPENTitle: Pathogenic LRRK2 regulates ciliation probability upstream of tau tubulin kinase 2 via Rab10 and RILPL1 proteinsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 118Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2005894118Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7958464Citation Count: 81
- Longitudinal assessment of the association between pesticide exposure and lifestyle with Parkinson’s disease motor severity2025OPENTitle: Longitudinal assessment of the association between pesticide exposure and lifestyle with Parkinson’s disease motor severityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01010-2Best OA location URL: https://www.nature.com/articles/s41531-025-01010-2.pdfCitation Count: 0
-
OPENTitle: Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patientsJournal Name: Toxicology ReportsPublisher: Elsevier BVVol: 4Issue #:Start Page: 188End Page: 193Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.toxrep.2017.03.005Best OA location URL: https://ars.els-cdn.com/content/image/1-s2.0-S221475001730015X-fx1_lrg.jpgCitation Count: 25
- Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s Disease2016OPENTitle: Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2016.00271Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2016.00271/pdfCitation Count: 7
- Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and function2022OPENTitle: Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and functionJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01374-zBest OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-022-01374-zCitation Count: 9
-
OPENTitle: Design, synthesis, and in vitro evaluation of quinolinyl analogues for α-synuclein aggregationJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 28Issue #: 6Start Page: 1011End Page: 1019Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.bmcl.2018.02.031Best OA location URL: https://doi.org/10.1016/j.bmcl.2018.02.031Citation Count: 17
- The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN212018OPENTitle: The E3 Ubiquitin Ligases TRIM17 and TRIM41 Modulate α-Synuclein Expression by Regulating ZSCAN21Journal Name: Cell ReportsPublisher: Elsevier BVVol: 25Issue #: 9Start Page: 2484End Page: 2496.e9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2018.11.002Best OA location URL: http://www.cell.com/article/S2211124718317315/pdfCitation Count: 36
- MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson’s HLA locus exhibits epigenetic regulation2025OPENTitle: MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson’s HLA locus exhibits epigenetic regulationJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-025-95679-3Best OA location URL: https://www.nature.com/articles/s41598-025-95679-3.pdfCitation Count: 0
-
OPENTitle: Sex and Gender Influence Urinary Symptoms and Management in Multiple System AtrophyJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 16Issue #: 2Start Page: 196End Page: 201Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.23016Best OA location URL: https://www.e-jmd.org/upload/jmd-23016.pdfCitation Count: 6
- LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In Vivo2021OPENTitle: LRRK2 Ablation Attenuates Alpha-Synuclein–Induced Neuroinflammation Without Affecting Neurodegeneration or Neuropathology In VivoJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 18Issue #: 2Start Page: 949End Page: 961Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1007/s13311-021-01007-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-021-01007-8.pdfCitation Count: 12
- A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease2016OPENTitle: A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s DiseaseJournal Name: Cell SystemsPublisher: Elsevier BVVol: 4Issue #: 1Start Page: 60End Page: 72.e4Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cels.2016.11.006Best OA location URL: http://doi.org/10.1016/j.cels.2016.11.006Citation Count: 448
- Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism2022OPENTitle: Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonismJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 182Issue #:Start Page: 106338End Page: 106338Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.phrs.2022.106338Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9733952Citation Count: 12
- Single-Molecule Fingerprinting Reveals Different Growth Mechanisms in Seed Amplification Assays for Different Polymorphs of α-Synuclein Fibrils2024OPENTitle: Single-Molecule Fingerprinting Reveals Different Growth Mechanisms in Seed Amplification Assays for Different Polymorphs of α-Synuclein FibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 15Issue #: 18Start Page: 3270End Page: 3285Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00185Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11413846Citation Count: 1
- CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of Synaptopathies2018OPENTitle: CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of SynaptopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 10Issue #: 3Start Page: 1729End Page: 1743Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1021/acschemneuro.8b00620Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6429430Citation Count: 41
- Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease2018OPENTitle: Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 55Issue #:Start Page: 8End Page: 14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.08.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6291234Citation Count: 42
- Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II‐mediated respiration2016OPENTitle: Loss of Pink1 modulates synaptic mitochondrial bioenergetics in the rat striatum prior to motor symptoms: concomitant complex I respiratory defects and increased complex II‐mediated respirationJournal Name: PROTEOMICS – Clinical ApplicationsPublisher: WileyVol: 10Issue #: 12Start Page: 1205End Page: 1217Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/prca.201600005Best OA location URL: http://doi.org/10.1002/prca.201600005Citation Count: 30
-
OPENTitle: PP1 Phosphatase Complexes: Undruggable No LongerJournal Name: CellPublisher: Elsevier BVVol: 174Issue #: 5Start Page: 1049End Page: 1051Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oa, elsevier-specific: oa user licenseDOI - Digital Object Identifier: 10.1016/j.cell.2018.08.007Best OA location URL: http://www.cell.com/article/S0092867418310237/pdfCitation Count: 10
- Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice2021OPENTitle: Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic miceJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 30Issue #: 16Start Page: 1469End Page: 1483Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddab118Best OA location URL: https://academic.oup.com/hmg/article-pdf/30/16/1469/39351981/ddab118.pdfCitation Count: 17
- BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's disease2022OPENTitle: BDNF rs10501087, rs1491850 and rs11030094 polymorphisms associated with delayed progression in early-stage Parkinson's diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.1053591Best OA location URL: https://doi.org/10.3389/fneur.2022.1053591Citation Count: 1
-
OPENTitle: Network abnormalities among non‐manifesting Parkinson disease related LRRK2 mutation carriersJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 8Start Page: 2546End Page: 2555Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.24543Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.24543?download=trueCitation Count: 21
- Intensive whole-brain 7T MRI case study of volitional control of brain activity in deep absorptive meditation states2023OPENTitle: Intensive whole-brain 7T MRI case study of volitional control of brain activity in deep absorptive meditation statesJournal Name: Cerebral CortexPublisher: Oxford University Press (OUP)Vol: 34Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/cercor/bhad408Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10793575Citation Count: 28
-
OPENTitle: Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA‐PD StudyJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 12Start Page: 2269End Page: 2281Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29611Citation Count: 12
- Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model2020OPENTitle: Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent modelJournal Name: BMC Research NotesPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13104-020-04994-7Best OA location URL: https://bmcresnotes.biomedcentral.com/track/pdf/10.1186/s13104-020-04994-7Citation Count: 16
- Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease2023OPENTitle: Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s DiseaseJournal Name: PharmaceuticalsPublisher: MDPI AGVol: 16Issue #: 6Start Page: 883End Page: 883Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ph16060883Best OA location URL: https://www.mdpi.com/1424-8247/16/6/883/pdf?version=1686821531Citation Count: 15